Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| Dir | GORMAN KEVIN CHARLES | 620.9K | $85.66M | - |
| CEO | Gano Kyle | 140.4K | $19.37M | - |
| Dir | | 120.5K | $16.62M | - |
| Dir | RASTETTER WILLIAM H | 58.4K | $8.05M | - |
| Other | | 47.8K | $6.59M | - |
Transactions
16 transactions · page 14
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2017-02-06 | Lippoldt Darin | Chief Legal Officer | Sell | 821 | $43.13 | $35,409.73 | -100% | → |
| 2017-02-06 | Coughlin Timothy P | Chief Financial Officer | Sell | 963 | $43.14 | $41,543.82 | -0.7% | → |
| 2017-02-06 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sale+OE | 3,010 | $43.18 | $129,971.80 | -1.2% | → |
| 2017-02-03 | Bozigian Haig P. | Chief Development Officer | Sell | 1,375 | $42.57 | $58,533.75 | -1.2% | → |
| 2017-02-03 | Coughlin Timothy P | Chief Financial Officer | Sell | 1,500 | $42.55 | $63,825.00 | -1.1% | → |
| 2017-02-03 | Gano Kyle | Chief Business Development Off | Sell | 1,375 | $42.57 | $58,533.75 | -2.2% | → |
| 2017-02-03 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 3,125 | $42.55 | $132,968.75 | -1.2% | → |
| 2017-02-03 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 1,375 | $42.56 | $58,520.00 | -1.2% | → |
| 2017-02-03 | OBrien Christopher Flint | Chief Medical Officer | Sell | 1,500 | $42.50 | $63,750.00 | -4.1% | → |
| 2017-02-01 | RASTETTER WILLIAM H | Director | Sale+OE | 10,750 | $42.28 | $454,510.00 | -43.0% | → |
| 2017-01-17 | Bozigian Haig P. | Chief Development Officer | Sell | 1,625 | $40.63 | $66,023.75 | -1.4% | → |
| 2017-01-17 | Coughlin Timothy P | Chief Financial Officer | Sell | 1,750 | $40.65 | $71,137.50 | -1.3% | → |
| 2017-01-17 | Gano Kyle | Chief Business Development Off | Sell | 1,625 | $40.65 | $66,056.25 | -2.7% | → |
| 2017-01-17 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 3,750 | $40.65 | $152,437.50 | -1.5% | → |
| 2017-01-17 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 1,625 | $40.63 | $66,023.75 | -1.4% | → |
| 2017-01-17 | OBrien Christopher Flint | Chief Medical Officer | Sell | 1,750 | $40.66 | $71,155.00 | -5.0% | → |